BPC-157 (Oral) Research Guide

Full name: BPC-157 Oral Formulation (Arginate Salt)

An oral-stable formulation of BPC-157 using the arginate salt form. Provides systemic healing benefits through oral administration with particular gut and organ healing properties.

How BPC-157 (Oral) Works

Same mechanism as injectable BPC-157 but delivered orally. Upregulates VEGF, modulates NO system, and promotes gut mucosal healing through direct contact and systemic absorption.

Dosing Protocol

• Typical dose: 500 mcg - 1 mg
• Frequency: 1-2x daily
• Duration: 4-12 weeks
• Route: Oral capsule (arginate salt)

Reported Benefits

• Gut healing (direct contact)
• Liver protection
• Oral convenience
• Systemic anti-inflammatory
• No injection required

Potential Side Effects

• Mild nausea
• GI discomfort initially
• Lower potency than injectable

Research Citations

1. Oral BPC-157 in NSAID-induced gut damage (2020) - Oral administration prevented and reversed NSAID-induced gastric and intestinal lesions in rat models.
2. Stable gastric pentadecapeptide oral bioavailability (2019) - Arginate salt form maintained 45% bioavailability with preserved biological activity orally.

Related Healing & Recovery Compounds

• BPC-157 - Full Profile
• TB-500 - Full Profile
• Pentosan Polysulfate - Full Profile
• KPV - Full Profile
• Thymosin Beta-4 - Full Profile
• LL-37 - Full Profile

View full BPC-157 (Oral) profile with 3D molecule viewer →